Search

everythinglearnresearchcommunity

for

Search:↓

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Mimosine is toxic to animals, causing hair loss, infertility, and growth issues, but its exact harmful mechanism is unclear.

Finasteride may help reduce opioid use.

Endocrine disruptors may cause early hair loss.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Some skin, hair, and nail supplements can be toxic, interact with medications, affect lab tests, and may increase cancer risk.

Clinicians should understand tattoos to manage health issues, as tattoos can cause complications and affect medical assessments.

6-Gingerol from ginger may slow down hair growth by affecting certain enzymes and growth factors.

The zinc finger protein 3 in Arabidopsis thaliana reduces plant growth and root hair development.

Some nutritional supplements may help thicken hair in people with hair loss, but taking too much can cause side effects.

Hedgehog signaling is crucial for hair development, cadherins affect cell adhesion, neutrophils play a role in skin lesions, and BP230 autoantibodies impact skin stability.

IL-1β inhibits human hair follicle growth.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Cepharanthine and Trifluoperazine are effective against SARS-CoV-2.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Inhibiting TYK2 can restore hair growth in alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.